| PERIOD ENDING | 30-Sep-08 | 30-Sep-07 | | Total Revenue | 1,287 | 10,704 | | Cost of Revenue | 607 | 7,861 | | | Gross Profit | 680 | 2,844 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 3,493 | 5,056 | | Non Recurring |
-
|
-
| | Others | 180 | 284 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (2,992) | (2,496) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 39 | (200) | | Earnings Before Interest And Taxes | (2,954) | (2,697) | | Interest Expense | 934 | 255 | | Income Before Tax | (3,887) | (2,951) | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (3,887) | (2,951) | | | Non-recurring Events | | Discontinued Operations | (3,080) |
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (6,967) | (2,951) | | Preferred Stock And Other Adjustments | (853) | (3,627) | | | Net Income Applicable To Common Shares | ($7,820) | ($6,578) |
|
0.20% Nasdaq 
Income Statement
